Therapeutic Group: Anti Viral Presentation Ninavirâ„¢ 100 IV Infusion: Each vial contains Remdesivir INN 100 mg as lyophilized powder Description Remdesivir is a prodrug of a modified adenine nucleoside analog. Remdesivir undergoes efficient metabolic conversion in cells and tissues to active nucleoside triphosphate metabolite that inhibits viral RNA polymerases. Remdesivir is highly selective for viral […]
Therapeutic Group: Gynaecological Presentation RehanzilTM : Each Tablet contains Relugolix INN 40 mg, Estradiol BP 1 mg & Norethindrone Acetate USP 0.5 mg. Description Rehanzil is a combination of Relugolix, Estradiol (E2), and Norethindrone Acetate (NETA). Relugolix is a non-peptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby reducing the release of […]
Therapeutic Group: Others Presentation Rexilo 120: Each tablet contains Relugolix 120 mg. Description Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors, thereby, reducing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and consequently testosterone. Indications Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment […]
Therapeutic Group: Kinase inhibitor Presentation Regocent : Each tablet contains Regorafenib Monohydrate INN eq. to Regorafenib 40 mg. Description Regorafenib is a kinase inhibitor and it inhibits multiple membrane-bound and intracellular kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis, and maintenance of the tumor microenvironment. Regorafenib or its […]
Therapeutic Group: Cardiovascular Presentation Ranolazine 500 SR tablet: Each film-coated sustained release tablet contains Ranolazine INN 500 mg. Description Ranolazine has anti-ischemic and anti-angina effects that do not depend upon reduction in heart rate or blood pressure. It does not affect the rate-pressure product, a measure of myocardial work, at maximal exercise. Ranolazine at therapeutic […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Each round film coated tablet contains Ranitidine Hydrochloride BP equivalent to Ranitidine 150 mg. Description Neofast-S (Ranitidine) is a histamine H2 receptor antagonist. It inhibits basal and stimulated secretion of gastric acid. Neofast-S 150 is rapidly absorbed after oral administration. Food or antacid does not interfere with its absorption. […]
Therapeutic Group: Cardiovascular Presentation Ramoril 2.5 Plus: Each tablet contains Ramipril BP 2.5 mg and Hydrochlorothiazide BP 12.5 mg Ramoril 5 Plus: Each tablet contains Ramipril BP 5 mg and Hydrochlorothiazide BP 25 mg Description Ramipril is an angiotensin converting enzyme (ACE) inhibitor, which after hydrolysis to ramiprilat, blocks the conversion of angiotensin I to […]
Therapeutic Group: Cardiovascular Presentation Ramoril 1.25: Each film coated tablet contains Ramipril BP 1.25 mg. Ramoril 2.5: Each film coated tablet contains Ramipril BP 2.5 mg. Ramoril 5: Each film coated tablet contains Ramipril BP 5 mg. Ramoril 10: Each film coated tablet contains Ramipril BP 10 mg. Description Ramipril is an angiotensin converting enzyme […]
Therapeutic Group: Bone and Joint Disorder Presentation Aloxif : Each tablet contains Raloxifene Hydrochloride INN 60 mg. Description Raloxifene is a selective estrogen receptor modulator (SERM). The biological actions of Raloxifene are largely mediated through binding to estrogen receptor. This binding results in activation of certain estrogenic pathways and blockade of others. Raloxifene reduces resorption […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Racetril Capsule: Each capsule contains Racecadotril BP 100 mg. Racetril 10: Each sachet contains Racecadotril BP 10 mg granules for oral suspension. Racetril 30: Each sachet contains Racecadotril BP 30 mg granules for oral suspension. Description Racecadotril is a pure intestinal antisecretory active substance. It decreases the intestinal hypersecretion […]